Amylyx Pharmaceuticals, Inc. (AMLX) Stock News & Chart | StockAdder

(AMLX)

Amylyx Pharmaceuticals, Inc.

Stock chart and latest news for Amylyx Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

Amylyx Pharmaceuticals, Inc. News

PRO

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Apr 9, 2026 Yahoo Finance

Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment

Mar 31, 2026 Trefis

Amylyx (AMLX) -7.8%: Earnings Show $0 Revenue, Shelf Filing Adds Dilution Fear

Apr 3, 2026 Quiver Quantitative

Amylyx Pharmaceuticals Stock (AMLX) Opinions on Insider Purchase | AMLX Stock News

Dec 26, 2025 Business Wire

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 3, 2026 The Motley Fool

Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million

Jan 31, 2026 Seeking Alpha

Amylyx Pharmaceuticals: Back From The Dead (NASDAQ:AMLX)

Jan 27, 2026 Stock Titan

Amylyx investors can watch its Needham conference talk live April 15

Apr 8, 2026 GuruFocus

Amylyx Pharmaceuticals Inc (AMLX) Shares Up 6.66% on Apr 6

Apr 6, 2026 Sahm

The Bull Case For Amylyx Pharmaceuticals (AMLX) Could Change Following LUCIDITY Trial Enrollment Milestone Completion

Apr 2, 2026 Yahoo Finance

A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Reduced Losses And Late Stage Pipeline Progress

Mar 4, 2026 Stock Titan

AMLX SEC Filings - Amylyx Pharmaceuticals 10-K, 10-Q, 8-K Forms